caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1831239391

Daniel ParkDO

Family PracticeWoodside, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Daniel Park's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
2690
Chang Ho Suk
Gastroenterology · Flushing, NY
2472
Yoon Yi
Podiatry · Flushing, NY
2055
David Lee
Ophthalmology · Flushing, NY
1764
Daniel Kim
Ophthalmology · Palisades Park, NJ
1423
Steve Kim
Otolaryngology · Fort Lee, NJ
1333
Jeffrey Lee
Diagnostic Radiology · Flushing, NY
1217
Kornylo Chorny
Diagnostic Radiology · Flushing, NY
1122
Cblpath, Inc
Clinical Laboratory · Rye Brook, NY
1118
Mrugank Shukla
Diagnostic Radiology · Lindenhurst, NY
1118
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
83
Unique beneficiaries
—
Total services
130
Distinct HCPCS
4
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,705 Family Practice providers in NY — bottom quintile (cohort median 473).
PRESCRIBING · PART D · 2024
Total Rx claims
6,329
Beneficiaries
—
Total drug cost
$808K
Distinct drugs
96
Brand share
28.8%
Top prescribed drugs
Amlodipine Besylate362 claims
Atorvastatin Calcium341 claims
Simvastatin318 claims
Icosapent Ethyl250 claims
Metformin Hcl245 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$340
Payment records
14
By payment type
Food and Beverage$340